About us

Edit Content

Chairman’s message

Edit Content

CEO Interview

Edit Content

Our Purpose

Chairman’s message

CEO Interview

Our Purpose

People

Edit Content

Shinya Moriuchi

Edit Content

Miriam Padilla​

Edit Content

Jennifer Alcock

Edit Content

Shinya Moriuchi​

Miriam Padilla​​

Jennifer Alcock​​​

Diego Martinez

Business Lines

Edit Content

Hemostasis

Edit Content

Acute Care Diagnostics

Edit Content

Autoimmunity

Edit Content

Original Equipment Manufacturing

Hemostasis

Acute Care Diagnostics

Autoimmunity

Original Equipment Manufacturing

Commercial Operations

Edit Content

Chief Commercial Officer’s message

Edit Content

North America

Edit Content

Europe

Edit Content

Latin America

Edit Content

EEMEA

Edit Content

APAC

Edit Content

China

Chief Commercial Officer’s message

North America

Europe

Latin America

EEMEA

APAC

China

Innovation

Edit Content

Hemostasis & Acute Care Diagnostics

Edit Content

Autoimmunity

Edit Content

OEM

Edit Content

VP Digital Solutions’ message

Hemostasis & Acute Care Diagnostics

Autoimmunity

OEM

VP Digital Solutions’ message

Spotlight

Edit Content

We Venture Capital

Edit Content

Chief Information Officer’s message

We Venture Capital

Chief Information Officer’s message

We Venture Capital

Chief Information Officer’s message

VP Digital Solutions

Helping our customers elevate their operational efficiency and productivity by supplying invaluable data to aid lab management

Digital Factory

2022 marked the first year of operations for the Werfen Digital Factory. Based at our Headquarters and Technology Center in Bedford, MA, this state-of-the art, collaborative workspace, comprised of highly skilled professionals, centralizes key competencies and agile working methodologies, to accelerate the development of digital solutions.

Our initial focus is on the development of Lab and Clinical-Decision Support tools, as well as Remote Service. This will allow us to help our customers elevate their operational efficiency and productivity by supplying invaluable data to aid lab management and clinical outcomes.

To this end, in 2022, we initiated development of our first Clinical Decision-Support solution, and expanded development of our ProDx solution for Remote Instrument Service. Additionally, we initiated development of cloud-based technology for next-generation solutions.

Longer-term, our focus will expand to the development of specialized digital ecosystems for enhanced customer engagement, operational efficiencies, and advanced clinical support. Ultimately, we believe this will help contribute to better patient care.

Nilesh Kumar

Digital Factory Leader

of Digital Solutions

Clinical Software

Since 1995, Clinical Software (CSW), based in the Barcelona area, has focused on the design and development of software to power Werfen’s Specialized Diagnostic portfolio. This includes Hemostasis, Acute Care, and Autoimmunity, as well as enterprise software solutions, such as LIS. Over the years, we built a strong practice, anchored in state-of-the-art processes, technologies and cybersecurity in medical-device software domains, with outstanding talent and innovative ways of working.

In 2022, CSW joined the newly established Digital Solutions team. By combining our expertise with that of the Digital Factory, along with our tools, manufacturing, service and quality management system, we have created a robust, synergistic and collaborative organization.

This will allow us to not only maintain our current level of excellence and product delivery, but to accelerate innovation in the digital environment, anticipate the future needs of our customers, and deliver the highest quality solutions.

Josep Ejarque

Vice President, Clinical Software

2022 Highlights

Regarding the achievements and challenges that Clinical Software has significantly contributed towards, we would highlight the following:  
  • Specialized data managers and middleware solutions for Hemostasis, Acute Care Diagnostics, Autoimmunity and other clinical areas are key components in our strategy. Clinical Software has been and continues to be crucial in the development and evolution of these systems. Keeping these systems technologically up to date is a must, and during this year important advances have been made.
  • Significant contribution to the development of next generation instrumentation projects, facilitating the achievement of planned milestones key to bringing products to market on time.
  • The IT Support Services Center of Excellence has been consolidated under the leadership of Clinical Software.
  • A strong cybersecutity team has continued to evolve and grow, in close collaboration with Product Privacy and Security Office (PPSO). An internship program has been created in collaboration with local universities. The program allows the PPSO to identify, attract and grow young talent.

In addition to these achievements, in 2022 we focused efforts on process harmonization, and agile software development methodology has become part of our DNA. We have also embraced DevOps methodologies to take us to the next level.

2022 Highlights

Regarding the achievements and challenges that Clinical Software has significantly contributed towards, we would highlight the following:  
  • Specialized data managers and middleware solutions for Hemostasis, Acute Care Diagnostics, Autoimmunity and other clinical areas are key components in our strategy. Clinical Software has been and continues to be crucial in the development and evolution of these systems. Keeping these systems technologically up to date is a must, and during this year important advances have been made.
  • Significant contribution to the development of next generation instrumentation projects, facilitating the achievement of planned milestones key to bringing products to market on time.

2022 Highlights

  • The IT Support Services Center of Excellence has been consolidated under the leadership of Clinical Software.
  • A strong cybersecutity team has continued to evolve and grow, in close collaboration with Product Privacy and Security Office (PPSO). An internship program has been created in collaboration with local universities. The program allows the PPSO to identify, attract and grow young talent.
  In addition to these achievements, in 2022 we focused efforts on process harmonization, and agile software development methodology has become part of our DNA. We have also embraced DevOps methodologies to take us to the next level.
rotate your devicePlease rotate your device